JURA Bio
JURA Bio, Inc. is an AI-native drug discovery and development company focused on genomic medicine. They combine next-generation machine inference with large-scale biological datasets and autonomously optimized iterative design. Their platform, Vista, utilizes AI to discover and develop drugs, including a focus on therapeutic antibodies against intracellular cancer targets and generative models for DNA and RNA sequences. JURA Bio emphasizes their proprietary biological data generation through Manufacturing Aware Generative Model Architectures (MAGMA), which significantly reduces costs and accelerates development in areas like genomic medicine and biosensors.
JURA Bio
JURA Bio, Inc. is an AI-native drug discovery and development company focused on genomic medicine. They combine next-generation machine inference with large-scale biological datasets and autonomously optimized iterative design. Their platform, Vista, utilizes AI to discover and develop drugs, including a focus on therapeutic antibodies against intracellular cancer targets and generative models for DNA and RNA sequences. JURA Bio emphasizes their proprietary biological data generation through Manufacturing Aware Generative Model Architectures (MAGMA), which significantly reduces costs and accelerates development in areas like genomic medicine and biosensors.